Inhibition of Cell-Mediated Immunity by the Histone Deacetylase Inhibitor Vorinostat:Implications for Therapy of Cutaneous T-Cell Lymphoma

類似資料

• The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T cell lymphoma patients
  著者:: Kelly-Sell, Michael J., 等
  出版事項: (2012)
• Increased Programmed Death-1 Expression on CD4(+) T Cells in Cutaneous T-Cell Lymphoma: Implications for Immune Suppression
  著者:: Samimi, Sara, 等
  出版事項: (2010)
• Immunopathogenesis and therapy of cutaneous T cell lymphoma
  著者:: Kim, Ellen J., 等
  出版事項: (2005)
• Immunopathogenesis and therapy of cutaneous T cell lymphoma
  著者:: Kim, Ellen J., 等
  出版事項: (2007)
• Immune Modulators as Therapeutic Agents for Cutaneous T-Cell Lymphoma
  著者:: Rook, Alain H., 等
  出版事項: (2010)